期刊
MOLECULAR ONCOLOGY
卷 2, 期 2, 页码 153-160出版社
WILEY
DOI: 10.1016/j.molonc.2008.05.003
关键词
Cancer biomarkers; Nanobiotechnology; Nanooncology; Oncoproteomics; Personalized medicine; Proteomics
类别
Oncoproteomics is playing an increasingly important role in the diagnosis and management of cancer as well as in the development of personalized treatment of cancer. Innovative proteomic technologies relevant to cancer are described briefly, which are helping in the understanding of mechanism of drug resistance in cancer and will provide some leads to improve the management. Most important of these are nanoproteomics, i.e. application of nanobiotechnology to proteomics is playing an important role in nanooncology. Examples of some cancers will be given to point out the challenges and future prospects of oncoproteomics including those involving translation of technologies from the bench to the bedside. (C) 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据